missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ PPP1R8 Polyclonal Antibody
Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA581242
This item is not returnable.
View return policy
Description
This antibody has specificity for Human NIPP1/Ppp1r8.
This gene, through alternative splicing, encodes three different isoforms. Two of the protein isoforms encoded by this gene are specific inhibitors of type 1 serine/threonine protein phosphatases and can bind but not cleave RNA. The third protein isoform lacks the phosphatase inhibitory function but is a single-strand endoribonuclease comparable to RNase E of E. coli. This isoform requires magnesium for its function and cleaves specific sites in A+U-rich regions of RNA.
Specifications
| PPP1R8 | |
| Polyclonal | |
| Unconjugated | |
| PPP1R8 | |
| 6330548N22Rik; activator of RNA decay; ARD1; ARD-1; AU044684; LOC100722083; NIPP1; NIPP-1; NIPP-1, nuclear inhibitor of protein phosphatase-1; Nuclear inhibitor of protein phosphatase 1; nuclear inhibitor of protein phosphatase-1 alpha; nuclear inhibitor of protein phosphatase-1 beta; nuclear subunit of PP-1; Ppp1r8; PRO2047; protein phosphatase 1 regulatory inhibitor subunit 8; protein phosphatase 1 regulatory subunit 8; protein phosphatase 1, regulatory (inhibitor) subunit 8; protein phosphatase 1, regulatory inhibitor subunit 8; protein phosphatase 1, regulatory subunit 8; RNase E | |
| Rabbit | |
| Antigen Affinity Chromatography, Protein A | |
| RUO | |
| 5511 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Western Blot, Immunocytochemistry | |
| 1 mg/mL | |
| PBS with 0.03% ProClin 300; pH 7 | |
| Q12972 | |
| PPP1R8 | |
| A synthetic peptide corresponding to the C-terminus of the Human NIPP1/PPP1R8. | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction